Mergers & Acquisitions
Care Homes, Nursing Homes

Long-term care is financed in one of four ways, and the distinction determines what an acquirer is buying.

Tax-funded universal systems (Denmark, Norway, Sweden). Services on assessed need, funded from general taxation, with the highest public spending shares. Revenue is procurement-driven, the counterparty is a municipality, private pay is limited.

Mandatory long-term care insurance (Germany, Japan, Luxembourg, the Netherlands, South Korea). Dedicated social insurance contributions and the highest coverage rates of the four. Revenue is negotiated rather than market-set, fee increases require agreement and reach the operator late, and the resident bears a defined co-payment.

Hybrid systems (Australia, and in differing form France). Universal entitlement with an income-related contribution. Revenue combines a regulated care component with a partly free accommodation component, so value depends on the mix.

Means-tested safety nets (the United States, England). Public funding only below defined thresholds, with a substantial share of demand privately paid. Pricing power exists, occupancy follows the local economy, and the catchment area matters more than the payor contract.

Why this is the first question in a cross-border process. Two homes with identical occupancy, staffing and buildings produce different earnings, different volatility and different acquirer interest depending on the system they sit in. An acquirer experienced in one system mis-prices the others in a predictable direction: it treats regulated fee income as contracted revenue, and it underestimates how long a cost increase takes to reach the top line.

This is the structural feature of European care that international buyers most often overlook.

A large share of European care homes are operated under long leases from listed or institutional landlords. Rent is typically indexed and rises automatically. Fees, in most European systems, do not: they require negotiation or approval. When inflation rises, the landlord's income adjusts immediately and the operator's income adjusts late, if at all.

The resulting measure is rent cover, the ratio of property-level earnings to rent. It is the first number a European care investor asks for, and it decides whether a lease is sustainable or will have to be renegotiated. A business with strong occupancy and weak rent cover is a distressed asset. A business with modest occupancy and comfortable rent cover is not.

The same mechanism explains a divergence between countries. Where fee increases require payor approval, the lag is longest. Where a large share of residents pay privately and fees are uncapped, cost increases pass through quickly. (the country characterisation has to be made)

For an owner the practical consequence is that occupancy alone does not describe the position of the business, and for an acquirer it is that a lease inherited unexamined can consume the return on the acquisition.

ConAlliance is headquartered in Germany, and the majority of the cross-border processes we run have a German or DACH party on one side. Three features distinguish the region.

Germany funds care through mandatory long-term care insurance. Volume is predictable; pricing is not. Fees are negotiated with payors and reach the operator late, while wage costs are fixed by tariff obligation and by statutory staffing requirements. That gap is the structural reason why a substantial share of recent ownership changes in German care arose from insolvency rather than from a decision to sell, and it is why timing matters more here than in a private-pay market.

The market is fragmented and consolidates slowly. The thirty largest residential operators hold roughly a quarter of places. The remainder sits with small and mid-sized providers, which is where the transactions are.

Germany: Four sub-markets, four different buyer sets

Austria and Switzerland follow different funding logics, tax-financed and cantonal respectively, and both have produced operators that acquire across the border into Germany.

Consolidation in Europe has a home base. Of the ten largest for-profit residential elderly care providers in Europe by revenue, five are French; the remainder are German, British, Swedish and Swiss. France exported a model of debt-financed, real-estate-backed, cross-border consolidation earlier and more aggressively than any other European market, and the largest European groups are the result.

That model has been re-priced. Governance and quality failures at one of the largest operators triggered regulatory scrutiny, refinancing pressure and a lasting change in investor sentiment. The consequence for a seller is concrete: quality, staffing and governance diligence is now conducted with an intensity that did not exist before, and an unblemished regulatory record has become a price argument rather than a hygiene factor.

Staffing, not demand, is the binding constraint. Formal long-term care workers per hundred people aged over 65 vary by a factor of two or more across the OECD. The shortage is structural rather than cyclical, reflecting pay levels, working conditions and the size of the cohort entering the labour market. Any valuation built from licensed rather than from staffed and occupied capacity overstates the business.

What follows for the buyer universe. The acquirers capable of paying the most for a European care business are frequently headquartered in another European country, and the acquirers of the real estate frequently in a third. A process confined to domestic buyers omits the group for whom the acquisition is a market-entry decision rather than an incremental one.

Demand is demographic and therefore forecastable. Supply is fiscal and political and therefore not. The share of the population aged over 65 in OECD countries is on a path to rise by roughly half again by mid-century, which is as close to certain as an economic projection gets. What is not certain is how much of the resulting need will be publicly funded, and that is the variable that determines the addressable market. The serious risks in this sector sit on the funding side, not the demand side.

Three distinct investment logics. North American investors approach care primarily through real estate structures and have moved from pure net lease towards arrangements that participate in operating results. European investors approach it through operating platforms with separately held property. Asian markets are building capacity domestically and importing operating know-how rather than exporting capital. The three meet in Europe, which is why the buyer list for a mid-sized European care business is international while the service itself remains local.

The transaction market is cyclical, the acquisition rationale is not. Volumes and valuation levels move with the financing environment. The structural reason for acquiring does not: operators need density to carry central cost and investors need scale to justify platform overhead, and neither motive is suspended in a weak year. A difficult market is an argument about timing and process design, not an argument against a process.

Pan-European operating groups. They acquire for density within a country and for entry into a new one. Entry acquisitions attract the highest prices, because the acquirer is buying a licensed, staffed, operating platform that cannot be built quickly in an unfamiliar regulatory system. Density acquisitions attract disciplined prices, because the acquirer has alternatives.

Domestic consolidators with international ownership. In several European markets the leading national operators are held by international financial investors. The commercial counterparty is domestic; the capital and the investment criteria are not.

Healthcare real estate investors. Listed property companies, funds and REITs acquire the buildings separately from the operations. For an owner holding both, the choice between a combined sale, two separate processes, or a property sale followed by an operations sale on a newly set rent is the decision that most often determines total proceeds.

Adjacent healthcare groups. Providers of home respiratory therapy, oxygen, nutrition and medical supplies acquire care providers to extend an existing chain of supply to the patient. They are frequently the highest bidder for specialised, high-acuity providers, because the acquisition secures access rather than adding volume.

Our access rests on mandate relationships. In our own care mandates the acquiring parties have included international groups, and we have acted for acquirers as well as for sellers. In a sale process we act exclusively for the selling side; a firm without buy-side mandates maybe does not have that conflict, and does maybe not have the access either.

Six measures travel across borders. Their weight changes with the funding system; their relevance does not.

1. Staffed and occupied capacity, not licensed capacity. The first number an acquirer asks for, as a monthly series over at least twenty-four months with a stated reason for every decline.

2. Rent cover. In leasehold structures it determines financeability. In freehold structures its shadow price determines what the property is worth to a separate buyer.

3. Payor mix and pricing mechanism. What share of revenue is publicly funded, negotiated or privately paid, and how long does a cost increase take to reach the top line? Two businesses with the same margin and different answers are not comparable.

4. Staffing quality and agency dependence. A persistently high agency share is a structural margin problem and is not accepted as a one-off adjustment.

5. Regulatory and quality record. Inspection history, open enforcement matters, and the durability of any exemption the business relies on.

6. Key-person dependency. Where payor relationships, recruitment and referral sources sit with one shareholder, an acquirer shifts consideration into deferred structures. This can be reduced before a process and not during one.

What is not a value driver. The number of sites, the age of the business, the breadth of the offering, and awards. These feature prominently in company presentations and play no part in pricing.

Confidentiality. In care, three groups notice a process before it concludes: staff, who in a shortage market can move at short notice; payors and commissioners, with whom fee or contract negotiations are running; and residents and their families, for whom ownership is a decision criterion. A process that becomes known early costs staff and admissions, which are the two measures the price depends on.

ConAlliance works to the following principles. The business is given a code name and the initial approach is anonymised in a form that does not permit identification by region and size. Information is released in stages and the data room is opened section by section and only against a signed confidentiality undertaking. Site visits take place in the second round and are arranged with local management. The client decides the timing and sequence of internal communication on our recommendation. Domestic competitors are approached only on express release of the individual name. ConAlliance brings decades of experience in advising corporate transactions across the Care Services segment, and we understand how to run processes under the highest confidentiality standards.

Additional requirements in a cross-border process. Regulatory diligence has to be organised per jurisdiction and cannot be extrapolated from one country to another. Transaction documentation, warranty practice and customary indemnity structures differ by market. Where operations and property are sold into two different buyer markets, two approaches run in parallel and their sequencing determines the outcome. Language and time zones are a scheduling matter rather than a substantive one, but they lengthen every round.